Work

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells

Year: 2026
Type: article
Abstract: cell proliferation, enhanced histone and tubulin acetylation, upregulated p21, and downregulated Bcl-2. These findings identify biphenyl-substituted UBHAs as promising therapeutics and probes to dissect HDAC biology.
Language: English
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7158600696
FWCI:
Cites: 65
Cited by:
Related to: